MAT prescriptions may be associated with a mild increased risk of posterior NIU in the real-world setting, but not the low inflammatory risk setting, compared with SSRIs. These findings suggest a potential benefit of ophthalmologic monitoring in patients prescribed MAT, although institutional studies reviewing each medication are necessary to confirm these results.
Building similarity graph...
Analyzing shared references across papers
Loading...
Matthew J. Schulgit
Cleveland Clinic
Ashley Hailer
Case Western Reserve University
Margaret G. Miller
Case Western Reserve University
Ocular Immunology and Inflammation
Case Western Reserve University
Cleveland Clinic
MetroHealth
Building similarity graph...
Analyzing shared references across papers
Loading...
Schulgit et al. (Tue,) studied this question.
synapsesocial.com/papers/69d895206c1944d70ce06233 — DOI: https://doi.org/10.1080/09273948.2026.2639733
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: